This regulation defines the purpose, the operational processes, and the organization of the registry BEAT-SHOCK (Basel Evaluation of Acute Therapy in cardiogenic SHOCK). It describes the requirements for collecting, storing, processing, managing and sharing health-related registry data.

• Patients admitted with cardiogenic shock to the University hospital Basel (diagnosis at the time of admission) or development of cardiogenic shock during the hospital stay
• Age ≥18 years
• Provision of written ICF
• Clinical diagnosis of cardiogenic shock.
• impaired organ perfusion due to primary cardiac dysfunction,
• persistent systolic blood pressure (SBP) <90 mmHg for ≥30 minutes, or the need for vasopressors, inotropes, or mechanical circulatory support (MCS) to maintain adequate perfusion and
• evidence of systemic hypoperfusion with arterial lactate ≥2 mmol/L or venous lactate ≥3 mmol/l and ≥1 of the following:
• Cold or clammy extremities
• Altered mental status
• Reduced urine output
• Signs of volume overload or congestion (on clinical exam, imaging, or invasive monitoring)
• Patients with normotensive cardiogenic shock (SBP ≥90 mmHg without vasopressors or MCS) may also be included if clear signs of hypoperfusion (arterial lactate ≥2 mmol/L or venous lactate ≥3 mmol/l) and cardiac dysfunction are present and alternative causes are excluded

Exclusion criteria:

• Age <18 years
• Refusal to provide informed consent by the patient or their legally authorized representative

Adult patients who are treated at the University Hospital Basel and are diagnosed with cardiogenic shock, irrespective of underlying etiology or therapeutic strategy. The registry includes a wide range of cardiogenic shock etiologies, including:

• Myocardial infarction (MI)
• Fulminant myocarditis
• Acute decompensated heart failure
• Severe valvular disease
• Post-cardiotomy or perioperative cardiogenic shock

Not necessary, only data registry.